Active Pharmaceutical Ingredients (APIs)

  • Tofacitinib Citrate*

    • API Product   :   

      Tofacitinib Citrate*

    • CEP   :   

      -

    • WCC   :   

      -

    • Therapeutic Use    :   

      Nonsteroidal products for inflammatory skin disorders; Immunosuppressants; Respiratory System; Anti-Inflammatory And Anti-Rheumatic Products

    • Originator   :   

      PFIZER

    • CAS No.    :   

      477600-75-2

    • Trade Name.   :   

      XELJANZ

    • Molecular Weight   :   

      312.369 g/mol

    • Molecular Formula   :   

      C16H20N6O

    Application

    Tofacitinib is an oral drug used for treating rheumatoid arthritis. It belongs to a class of drugs called Janus kinase (JAK) inhibitors.

    General Description

    Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.[1][2] Common side effects include diarrhea, headache, and high blood pressure.[1] Serious side effects may include infections and the development of cancer.[1] It is in the janus kinase (JAK) inhibitor class, discovered and developed by the National Institutes of Health and Pfizer.